Holen Sie sich die Stockscreener-App
2.02
3.02%
0.03
Curis Inc Aktie (CRIS) Neueste Nachrichten
Curis Approves Key Amendments at Annual Meeting - TipRanks
What is HC Wainwright’s Estimate for Curis Q2 Earnings? - Defense World
Curis (NASDAQ:CRIS) Receives Buy Rating from HC Wainwright - Defense World
Curis (CRIS) Sees Positive Rating Action from HC Wainwright & Co - GuruFocus
Curis assumed with a Buy at H.C. Wainwright - TipRanks
H.C. Wainwright sets $17 target for Curis stock with Buy rating - Investing.com Nigeria
Curis (CRIS) Gains Buy Rating with Promising Cancer Therapy Deve - GuruFocus
Curis (CRIS) Gains Buy Rating with Promising Cancer Therapy Developments | CRIS Stock News - GuruFocus
Curis Provides Third Quarter 2023 Business Update - Seeking Alpha
Curis (NASDAQ:CRIS) Now Covered by Analysts at StockNews.com - Defense World
FY2025 EPS Estimates for Curis Reduced by Cantor Fitzgerald - Defense World
Curis highlights progress in lymphoma and AML trials with expanded patient enrollment - MSN
Curis, Inc. (NASDAQ:CRIS) Q1 2025 Earnings Call Transcript - Insider Monkey
Analysts Offer Insights on Healthcare Companies: Curis (CRIS), Ardent Health Partners, Inc. (ARDT) and Agilon Health (AGL) - The Globe and Mail
Curis (NASDAQ:CRIS) Coverage Initiated at StockNews.com - Defense World
Curis (CRIS) Reports Q1 Loss, Tops Revenue Estimates - MSN
Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | CRIS Stock News - GuruFocus
Curis Inc (CRIS) Q1 2025 Earnings Call Highlights: Financial Improvements and Strategic Developments - Yahoo Finance
Curis Inc (CRIS) Q1 2025 Earnings Call Highlights: Financial Imp - GuruFocus
Curis Inc (CRIS) Q1 2025 Earnings Call Highlights: Financial Improvements and Strategic Developments By GuruFocus - Investing.com Canada
Curis Inc. Reports Q1 2025 Progress and Financials - TipRanks
Curis Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Curis Inc. Earnings Call: Clinical Advances Amid Cash Concerns - TipRanks
Curis: Q1 Earnings Snapshot - MySA
Curis Q1 2025 Earnings Call Transcript - MarketBeat
Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - GuruFocus
Curis, Inc. (CRIS) Advances Emavusertib Studies with Positive Da - GuruFocus
Curis (CRIS) Strengthens Leadership with New Chief Medical Officer | CRIS Stock News - GuruFocus
Curis appoints Ahmed Hamdy as Chief Medical Officer - TipRanks
Curis reports Q1 EPS ($1.25), consensus ($1.26) - TipRanks
Earnings call transcript: Curis Inc. Q1 2025 sees stock surge despite losses - Investing.com India
Curis Provides First Quarter 2025 Business Update - StreetInsider
Curis (CRIS) Expands Leadership and Advances Clinical Studies | - GuruFocus
Curis Provides First Quarter 2025 Business Update | CRIS Stock N - GuruFocus
Curis Inc (CRIS) Q1 2025 Earnings: EPS of -$1.25 Misses Estimates, Revenue of $2.4M Falls Short - GuruFocus
Curis (CRIS) Expands Leadership and Advances Clinical Studies | CRIS Stock News - GuruFocus
Curis Provides First Quarter 2025 Business Update | CRIS Stock News - GuruFocus
CURIS INC SEC 10-Q Report - TradingView
Curis Inc Q1 Loss Decreases, Beats Estimates - Nasdaq
Curis Inc (CRIS) Q1 2025 Earnings Report Preview: What To Expect - GuruFocus
Curis Provides Third Quarter 2024 Business Update - Seeking Alpha
Geode Capital Management LLC Raises Position in Curis, Inc. (NASDAQ:CRIS) - Defense World
Curis FY2025 EPS Estimate Increased by Cantor Fitzgerald - Defense World
13.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):